From: Human papillomavirus infection in patients with laryngeal carcinoma
Characteristicsa | Value |
---|---|
Age (years) | |
Mean | 56.6 |
Range | 40-75 |
Gender | |
Male | 78 (95.1) |
Female | 4 (4.9) |
Primary Tumor Site, No. (%) | |
Supraglottis | 58 (70.7) |
Glottis | 24 (29.3) |
T Stage, No. (%) | |
T2 | 14 (17) |
T3 | 53 (64.7) |
T4 | 15 (18.3) |
N Stage, No. (%) | |
N0 | 46 (56) |
N1 | 10 (12.2) |
N2a | 3 (3.6) |
N2b | 10 (12.2) |
N2c | 10 (12.2) |
N3 | 3 (3.6) |
Stage, No. (%) | |
Stage II | 5 (6.1) |
Stage III | 38 (46) |
Stage Iva | 35 (43) |
Stage IVb | 4 (4.9) |
Histopathological Differentiation, No. (%) | |
Well-Differentiated | 33 (40.2) |
Moderately-Differentiated | 44 (53.7) |
Poorly-Differentiated | 5 (6.1) |
Chemotherapy Regimen, No. (%) | |
Induction CT + concomitant CRT | 46 (56.1) |
Concomitant CRT | 36 (43.9) |
Recurrence, No. (%) | |
Recurrence (+) | 35 (42.7) |
Recurrence (–) | 47 (57.3) |